Announcements Trials
Browse Landscape

Phase

Phase NA 17Phase 2 13Phase 1/2 11Phase 1 10Phase 4 3Phase EARLY_PHASE1 1Phase 3 1

Status

Withdrawn 1Not yet recruiting 1Completed 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 23Plasma cell 3Classical hematology 3Lymphoid 2Myeloid 1

Conditions

Anemia 30Neoplasms 21Febrile Neutropenia 19Venous Thromboembolism 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Neutropenia 5Leukemia, Myeloid, Acute 5Colorectal Neoplasms 5Pulmonary Embolism 4Myelodysplastic Syndromes 4Leukemia 4Fever 4Anemia, Iron-Deficiency 4Venous Thrombosis 3Thrombocytopenia 3Ovarian Neoplasms 3Multiple Myeloma 3Lymphoma, Non-Hodgkin 3Hematologic Neoplasms 3Breast Neoplasms 3Adenocarcinoma 3Vitamin D Deficiency 2Uterine Cervical Neoplasms 2Stomach Neoplasms 2Sepsis 2Recurrence 2Postoperative Complications 2Lymphoma, Follicular 2Lymphoma 2Infections 2

Interventions

Meropenem 2ceftolozane, tazobactam drug combination 1Vancomycin 1Teicoplanin 1Ofloxacin 1Metronidazole 1Ciprofloxacin 1Cilastatin, Imipenem Drug Combination 1Ceftazidime 1Cefepime 1Amikacin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 4 × Hematologic Neoplasms × Classical hematology × Clear all
NCT07590648 2026-05-15

E-STOP2

Hospital Universitari Vall d'Hebron Research Institute

Phase 4 Not yet recruiting
136 enrolled
Classical hematologyOther hematologic neoplasm

Neoplasms, Neutropenia, Hematologic Neoplasms, Febrile Neutropenia

NCT05061654 2023-08-14

CEF-10

Hamad Medical Corporation

Phase 4 Withdrawn
Classical hematologyOther hematologic neoplasm

Hematologic Neoplasms, Febrile Neutropenia

NCT02149329 2019-09-25

SHORT

Amsterdam UMC, location VUmc

Phase 4 Completed
276 enrolled
Classical hematologyOther hematologic neoplasm

Fever, Neoplasms, Neutropenia, Hematologic Neoplasms, Febrile Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡